NCT02209649View on ClinicalTrials.gov

Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

December 31, 1999

Conditions
Healthy
Interventions
DRUG

Lacidipine and Telmisartan fixed dose combination (FDC) tablet

DRUG

Lacidipine

DRUG

Telmisartan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY